Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780664-26-000041 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 16, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
106,929
Total Value
$1,330,061.61
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and COO | Common Stock | โ | Oct 14, 2026 | Exercise/Conversion | 11,881 | $12.14 | $144,235.34 | 389,683 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 14, 2026 | Sale | 6,781 | $25.57 | $173,390.17 | 382,902 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 14, 2026 | Sale | 5,100 | $25.82 | $131,682.00 | 377,802 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 11,881 | $12.14 | $144,235.34 | 389,683 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 15, 2026 | Sale | 11,881 | $25.61 | $304,272.41 | 377,802 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 16, 2026 | Exercise/Conversion | 11,881 | $12.14 | $144,235.34 | 389,683 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 16, 2026 | Sale | 11,581 | $24.21 | $280,376.01 | 378,102 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 16, 2026 | Sale | 300 | $25.45 | $7,635.00 | 377,802 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Oct 14, 2026 | Exercise/Conversion | 11,881 | $0.00 | $0.00 | 260,967 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 11,881 | $0.00 | $0.00 | 249,086 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Oct 16, 2026 | Exercise/Conversion | 11,881 | $0.00 | $0.00 | 237,205 | Direct | โ | View Details |